Innovate Retina TV

Innovate Retina PBM Intro

LATE-BREAKING CLINICAL TRIAL DATA

Diana V. Do, MD and colleagues discuss late-breaking data from the LIGHTSIGHT III
clinical trial on photobiomodulation (PBM) in dry AMD, with a high-level overview of PBM technology.

INNOVATE RETINA - PBM Panel

LATE-BREAKING CLINICAL TRIAL DATA

Will this technology provide meaningful improvements in patients’ vision?

Will FDA Approve Pegcetacoplan?

EXPERTS WEIGH IN ON NEW DATA

Hear what the experts have to say live from the Retina Society Meeting in this 5-minute video.

KOL Interviews - Will FDA Approve Pegcetacoplan

KOL INTERVIEWS

KOL VIDEOS live from the Retina Society Meeting in this 15-minute video.

OAKS and DERBY Efficacy and Safety Data Summary

OAKS and DERBY: Efficacy and Safety Data Summary

OAKS and DERBY: Efficacy and Safety Data Summary live from the Retina Society Meeting in this 11-minute video.